Gynecologic Cancer
📧 Sign up to get email alerts when something new happens for Gynecologic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-02-03Clinical Trial Update: Quality of Life Assessment of Radiotherapy in Recurrent Head and Neck Cancer [NA]
A clinical trial evaluating quality of life during radiotherapy for recurrent head and neck cancer has been withdrawn; the study also listed…
-
CLINICAL_TRIALS withdrawal · 2025-04-14Clinical Trial Update: Perioperative Management in Gynaecological Carcinoma Surgery [Phase 3]
A Phase 3 clinical trial evaluating perioperative management in gynecologic cancer surgery has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-06-26Clinical Trial Update: Lenvatinib and Capecitabine in Patients With Advanced Malignancies [Phase 1]
A Phase 1 study of lenvatinib in combination with capecitabine for patients with advanced cancers has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-04Clinical Trial Update: Delayed Effects of Treatment in Cancer Survivors (DETECS)
The DETECS clinical trial (NCT02067637) investigating delayed treatment effects in cancer survivors has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2011-06-28Clinical Trial Update: Safety of Regular Diet as the First Meal in Patients Who Underwent Surgical Treatment for Gynecologic Cancer [Phase 3]
A Phase 3 trial evaluating the safety of a regular diet as the first meal after gynecologic cancer surgery has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.